Our Science
Science & Innovation
Pipeline
Dorzagliatin
mGluR5
Poster and Presentation
Peer Reviewed Publications
Product
HuaTangNing(华堂宁®)
Investor Relations
Investor Center
Corporate Governance
Financial Report
Announcements and Circulars
Listing Documents
Investor Presentation
IR Contact
Investor Calendar
Stock Information
Corporate Communications
Media
Company News
Media Releases
Video
About Us
Company Overview
Company History
Leadership Team
Partner
Portfolio Advisory Board
Senior Scientific Advisory Board
Media Center
Careers
Company Culture
Join Us
Contact Us
中
繁
中
繁
中
Our Science
Science & Innovation
Pipeline
Dorzagliatin
mGluR5
Poster and Presentation
Peer Reviewed Publications
Product
HuaTangNing(华堂宁®)
Investor Relations
Investor Center
Corporate Governance
Financial Report
Announcements and Circulars
Listing Documents
Investor Presentation
IR Contact
Investor Calendar
Stock Information
Corporate Communications
Media
Company News
Media Releases
Video
About Us
Company Overview
Company History
Leadership Team
Partner
Portfolio Advisory Board
Senior Scientific Advisory Board
Media Center
Careers
Company Culture
Join Us
Contact Us
Investor Relations
>
Investor Relations
>
Announcements and Circulars
Investor Center
Corporate Governance
Financial Report
Announcements and Circulars
Listing Documents
Investor Presentation
IR Contact
Investor Calendar
Stock Information
Corporate Communications
Announcements and Circulars
Search
Feb 06, 2024
Monthly Return
Read More
Jan 05, 2024
Monthly Return
Read More
Dec 29, 2023
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Read More
Dec 29, 2023
APPOINTMENT OF EXECUTIVE DIRECTOR
Read More
Dec 21, 2023
VOLUNTARY ANNOUNCEMENT-IND APPLICATION OF 2nd GENERATION GLUCOKINASE ALLOSTERIC ACTIVATOR FILED WITH AND ACCEPTED BY FDA
Read More
Dec 13, 2023
VOLUNTARY ANNOUNCEMENT - INNOVATIVE FIRST-IN-CLASS GKA, HUATANGNING (华堂宁®) INCLUDED IN THE 2023 NATIONAL REIMBURSEMENT DRUG LIST
Read More
Dec 06, 2023
Monthly Return
Read More
Nov 22, 2023
VOLUNTARY ANNOUNCEMENT - BUSINESS UPDATE ON RECEIPT OF THE MILESTONE PAYMENT UNDER THE COMMERCIALIZATION AGREEMENT IN RELATION TO HUATANGNING
Read More
Nov 06, 2023
Monthly Return
Read More
Oct 12, 2023
List of Directors and their Role and Function
Read More
Oct 12, 2023
CHANGE OF NON-EXECUTIVE DIRECTOR AND CHANGE IN COMPOSITION OF REMUNERATION COMMITTEE
Read More
Oct 06, 2023
Monthly Return
Read More
<<
<
1
2
3
4
5
6
7
8
9
10
11
>
>>
上一页
下一页
About Us
Company Overview
Company History
Leadership Team
Portfolio Advisory Board
Senior Scientific Advisory Board
Partner
Media center
Research & Development
Inovation
Pipeline
Dorzagliatin
mGluR5
Company Publications
Peer Reviewed Publications
Investor Relations
Corporate Governance
Financial Report
Announcements & Circulars
Listing Documents
Investor Presentation
IR Contact
Investor Calendar
Stock information
Media
Company News
Media Releases
Video
Careers
Culture
Join Us
Product
HuaTangNing(华堂宁®)
Subscribe Email
Focus Us
Copyright © 2024 Hua Medicine (Shanghai) Co., Ltd. 互联网药品信息服务资格证书编号: (沪)-非经营-2022-0079
沪ICP备14036654号-1
沪公网安备 31011502013809号
Privacy Statement
Terms of Use
Search
How we use cookies
Hua Medicine uses cookies to enable and improve the use of the website. By continuing to use the site, you consent to the use of these cookies. To learn more about cookies, please read our
privacy statement
.
Accept
x
皇冠体育
皇冠现金网
冰球突破
Venice-Macao-sales@yzfycb.com
陆河网
Crown-cash-hr@cantergroupconsulting.com
Sun-City-official-website-help@iconfuture.net
恒丰银行
DOS之家
澳门新葡京
达海智能
天津订餐小秘书
银河集团app下载
Sun-City-Entertainment-feedback@abpe44.com
智飞生物
Gambling-app-marketing@changbbs.com
中航高科
威尼斯人网上赌场
太阳城
皇冠官方网站
内江第一城
设计师俱乐部
藁城在线-
网邻通
做到
三清山旅游网
丰财园佛教网
贵州天气网
DIY烧友会
大连东来国际旅行社官方网站
站点地图
黑河学院招生信息网
酷派商城